MAP selects Blue Yonder to enhance business processes
PT Map Aktif Adiperkasa Tbk (MAPA), the leading lifestyle retailer, has selected to enhance its business processes with Blue Yonder ’s SaaS-based Luminate Planning solutions. Based in Indonesia, MAPA (MAP Active) is a “brand commerce” entity managing and marketing international brands across Indonesia. A subsidiary of PT Mitra Adiperkasa Tbk (MAPI), MAP Active operate more than 40 exclusive brands […]
Escient Pharmaceuticals unveils USD120 million series C financing
Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the closing of a $120 million Series C financing. The financing was co-led by NEA, Abingworth, and Forge Life Science Partners with participation from other new investors Avego, PFM Health Sciences, and […]
China approves the use of ferinject to treat adult patients with iron deficiency
CSL Vifor and Fresenius Kabi today announced that China’s National Medical Products Administration (NMPA) has approved Ferinject, a preparation for intravenous iron therapy for the treatment of iron deficiency in adult patients for whom oral iron preparations are ineffective, oral iron preparations cannot be used or for whom there is a clinical need to deliver […]
Google Cloud creates an advisory council for its point carbon zero programm
Recently at Singapore FinTech Festival 2022, Google Cloud announced three key updates under the Point Carbon Zero Program, which was jointly launched in July with the Monetary Authority of Singapore (MAS) to catalyze the incubation and adoption of climate fintech solutions in Asia over the next three years. These updates include the appointment of an Advisory Board to guide the […]
CLI initiates two new onshore renminbi funds
CapitaLand Investment Limited (CLI) has established two new onshore renminbi (RMB) funds, China Business Park Core RMB Fund I (CBPCFI) and CBPCF II to invest in business park opportunities in China. CBPCF I is a RMB380 million (S$76 million) fund established with four new domestic investors and CBPCF II is a RMB3.6 billion (S$720 million) […]
